Postbiotica has signed a licensing agreement with Kalichem(a Lamberti company) leader in the dermocosmetic market, based on a well established R&D collaboration. Kalichem develops and commercializes functional ingredients for cosmetics...
Postbiotica has signed a licensing and commercialising agreement with Candioli Pharma, a company leader in the pet-care market. The agreement foresees the exclusivity of the postbiotic ImmunoFOS® as an active...
Necrotizing enterocolitis (NEC) primarily affects premature newborns, occurring in 7–10% of very low birth weight infants, from 2 weeks to 2 months of age, with an incidence inversely related to...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly becoming the most prevalent liver disease worldwide....
Gut bacteria depend fully on their host to provide the necessary nutrients that may promote microbiota growth. However, bacteria produce small molecular weight metabolites during their lifecycle; these compounds play...
The human gut is the habitat to trillions of microbial cells with over 1,000 diverse microbial species that contribute to the primary functions of the gastrointestinal tract, including nutrition and...